hims glp 1 cost introduces GLP-1 weight loss membership starting at $39 Hims GLP-1 Weight Loss Guide

Not approved for diagnostic, therapeutic, or medical applications

Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health

Evaluate the benefits and concerns surrounding GLP-1 treatments

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

FDA approval is anticipated in 2026, through the FDA's national priority voucher program, positioning Lilly to compete aggressively in the oral segment

The GLP1-RAs vs sodium-glucose cotransporter-2 (SGLT-2) inhibitors cohort included new users of GLP-1 RAs (n=83,464) or SGLT-2 inhibitors (n=78,366), and the GLP1-RAs vs dipeptidyl peptidase-4 (DPP-4) inhibitors cohort included new users of GLP-1 RAs (n=108,322) or DPP-4 inhibitors (n=55,411)